<DOC>
	<DOCNO>NCT01420094</DOCNO>
	<brief_summary>To compare safety efficacy ( onset , duration relief overall efficacy ) single dose fast release formulation aspirin 1000 mg compare acetaminophen 1000 mg placebo relief pain follow extraction impact third molar .</brief_summary>
	<brief_title>Evaluate Onset Action Fast Release Aspirin</brief_title>
	<detailed_description />
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Healthy , ambulatory , male female volunteer 16 45 year age Scheduled undergo surgical removal either two partial bony impaction one full bony alone combination partial bony impaction , soft tissue impaction erupt third molar . Maxillary third molar may remove regardless impaction level Use shortacting local anesthetic ( e.g. , mepivacaine lidocaine ) preoperatively , without vasoconstrictor nitrous oxide No use analgesic , nonsteroidal antiinflammatory drug ( NSAIDs ) , aspirin , pain reliever counter ( OTC ) prescription , herbal supplement within 5 day surgery . Oral contraceptive , prophylactic antibiotic , preanesthetic medication , anesthesia procedure , routine medication treat benign condition would confound evaluation investigational would acceptable Female subject childbearing potential must use medically acceptable form birth control least 1 month prior screen ( 3 month oral contraceptive ) , e.g. , oral patch contraceptive , intrauterine device , NuvaRing , DepoProvera , doublebarrier negative pregnancy test Screening prior surgery . Female subject nonchildbearing potential must amenorrheic least 2 year hysterectomy and/or bilateral oophorectomy Provide personally sign date informed consent indicate subject inform pertinent aspect trial , ( subject &lt; 18 year age must sign write assent parental guardian consent ) History hypersensitivity aspirin , salicylate , nonsteroidal antiinflammatory drug ( NSAIDs ) , acetaminophen , opioid analgesic , similar pharmacological agent component investigational product , include placebo Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic disease , malignancy Relevant concomitant disease asthma ( exercise induce asthma permit ) , chronic sinusitis nasal structural abnormality cause great 50 percent obstruction ( polyposis nasi , mark septal deviation ) interfere conduct study judgment Investigator Current past history bleeding disorder ( ) History gastrointestinal bleeding perforation , relate previous nonsteroidal antiinflammatory drug ( NSAID ) therapy . Active , history recurrent peptic ulcer/hemorrhage ( two distinct episode proven ulceration bleeding ) Acute illness local infection prior surgery interfere conduct study judgment Investigator Females pregnant lactate Positive alcohol breathalyzer test and/or positive urine drug cotinine test prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Drugs , Investigational</keyword>
	<keyword>Acetylsalicylic Acid</keyword>
	<keyword>Aspirin</keyword>
	<keyword>dental pain</keyword>
</DOC>